What's on the horizon for NSCLC?

What's on the horizon for NSCLC?

Cancer-News

2 months
41 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 1
Category:
Description:
Dr. Neal provides insight on the horizon for the upcoming year.
Up Next Autoplay
Cystic Renal Mass Treatment
Cystic Renal Mass Treatment
Category: Kidney Cancer
1 Views
kidneycancer 4 hours
Cystic Renal Masses: Active Surveillance
Cystic Renal Masses: Active Surveillance
Category: Kidney Cancer
0 Views
kidneycancer 4 hours
Phase 3 DUO Study @ospniguarda
Phase 3 DUO Study @ospniguarda
Category: Chronic Lymphocytic Leukemia
1 Views
Cancer-News 5 hours
Surgical Trial for RCC @CleClinicMD
Surgical Trial for RCC @CleClinicMD
Category: Kidney Cancer
3 Views
kidneycancer 5 hours
Phase 1/2 AUGMENT-101 Trial @sloan_kettering
Phase 1/2 AUGMENT-101 Trial @sloan_kettering
Category: Acute Lymphoblastic Leukemia
0 Views
Memorial Sloan Kettering 6 hours
Do We Still Need The P-Value? @MDAndersonNews
Do We Still Need The P-Value? @MDAndersonNews
Category: Kidney Cancer
6 Views
kidneycancer 1 day
Circulating Tumor DNA (ctDNA) Results in 110 Patients with Advanced Clear Cell Renal Cell Carcinoma
Circulating Tumor DNA (ctDNA) Results in 110 Patients with Advanced Clear Cell Renal Cell Carcinoma
Category: Kidney Cancer
8 Views
kidneycancer 1 day
Moleculin Announces Positive Trial Data with 100% Safe Delivery of p-STAT3 Inhibitor and Efficacy in Majority of Patients
Moleculin Announces Positive Trial Data with 100% Safe Delivery of p-STAT3 Inhibitor and Efficacy in Majority of Patients
Category: Non-Hodgkin Lymphoma
1 Views
Cancer-News 1 day
Importance of Paradigms for Precision Medicine @sloan_kettering
Importance of Paradigms for Precision Medicine @sloan_kettering
Category: News
0 Views
Memorial Sloan Kettering 1 day
Precision Medicine in Epichaperome Cancer Therapy @sloan_kettering
Precision Medicine in Epichaperome Cancer Therapy @sloan_kettering
Category: News
2 Views
Memorial Sloan Kettering 1 day